Skip to content
healthcare.dev

Cetirizine Hydrochloride

NDC 30142-058, Cetirizine Hydrochloride, tablet, orally disintegrating, from KROGER COMPANY.

Product NDC
30142-058
Status
Listed
Labeler
KROGER COMPANY
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA213557
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/30142-058 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
30142-058-76301420058764 BLISTER PACK in 1 CARTON (30142-058-76) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 30142-058 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/30142-058 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 30142-058. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.